DE69812681D1
(en )
2003-04-30
UNSUBSTITUTED POLYDIALLYLAMINES FOR THE TREATMENT OF HYPERCHOLESTEROLMIA
NO20005864D0
(en )
2000-11-20
Quinasols for the treatment of brain tumor
NO20006630L
(en )
2001-02-26
Pharmaceutical composition for the treatment of diabetes
AU2001247474A1
(en )
2001-09-24
Compounds for the treatment of psychiatric or substance abuse disorders
HUP9900927A3
(en )
2002-02-28
Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69737067D1
(en )
2007-01-18
VACCINE FOR THE TREATMENT OF MYCOSES
ITMI940317A0
(en )
1994-02-22
PROCEDURE FOR THE PRODUCTION OF GAMMA-BUTYROLACTONE
HK1017684A1
(en )
1999-11-26
Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases
NO993949L
(en )
1999-09-07
Process for the preparation of substituted thiazolidinedione
DE69729735D1
(en )
2004-08-05
USE OF BENZOPYRANOLS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
DE69735417D1
(en )
2006-05-04
2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
DE69834937D1
(en )
2006-07-27
ANTIBIOTICS FOR THE TREATMENT OF STOMACHES
DE69924284D1
(en )
2005-04-21
USE OF STIMULATORS OF NEUROTROPHIC FACTORS FOR THE TREATMENT OF NEURODEEGENERATIVE OPHTHALMIC DISEASES
HUP9901751A3
(en )
2004-09-28
Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
AUPP870999A0
(en )
1999-03-11
Method of treatment of equine disease
AU1820499A
(en )
1999-06-28
Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2253197A
(en )
1997-09-10
Novel substituted N-Methyl-N-(4-(4-(1H-benzimidazol- 2-yl){1,4}diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
NO985535D0
(en )
1998-11-27
Process for the preparation of 1,3-alkanediols
DE59802620D1
(en )
2002-02-21
Process for the preparation of trans- (R, R) -actinol
ZA971413B
(en )
1997-08-21
Novel substituted n-methyl-n-(4-(piperindin-1-yl)-2(aryl) butyl)benzamines useful for the treatment of allergic diseases.
AU5855899A
(en )
2000-03-21
Method for identifying substances for the treatment of c-jun-mediated disorders
DE60004931D1
(en )
2003-10-09
Continuous process for the preparation of 3,5,5-trimethylcyclohexa-3-en-1-one (beta-isophorone)
HK1019734A1
(en )
2000-02-25
Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
DE69819503D1
(en )
2003-12-11
USE OF 7-APHA-METHYL-17-ALPHA-ETHYNYL-ESTRANE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSE
ZA971323B
(en )
1997-08-27
Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin 1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases.